Live Webinar: From Onset to Outcome - Acute Kidney Injury Insights for Healthcare Professionals Live
Disease State Management/Drug Therapy CE for Pharmacist & Pharmacy Techs
Live Conference
Course Summary
Acute kidney injury (AKI) represents a dynamic clinical syndrome characterized by an abrupt decline in kidney function that leads to the accumulation of metabolic waste products and disturbances in fluid, electrolyte, and acid-base balance. Affecting hospitalized and outpatient populations, AKI is associated with significant morbidity, mortality, and increased risk of chronic kidney disease progression. The KDIGO (Kidney Disease: Improving Global Outcomes) AKI guidelines provide recommendations for staging, early identification, and management. The guidelines also focus on preventing contrast-induced nephropathy, mitigating medication-related injury, and optimizing transitions of care. This interprofessional continuing education activity emphasizes early recognition of AKI, elimination of precipitating factors such as nephrotoxins and hypotension, and evidence-based management strategies, including appropriate fluid resuscitation, diuretic use, and correction of electrolyte or acid-base disturbances. Learners will explore best practices for triaging patients, determining referral or emergency indications for kidney replacement therapy, and ensuring coordinated outpatient follow-up. Participants will enhance their ability to identify at-risk patients, manage AKI complications, and support recovery through effective teamwork among healthcare clinicians.
Recall the diagnostic and staging criteria for acute kidney injury (AKI) based on KDIGO (Kidney Disease: Improving Global Outcomes) guidelines
Compare and contrast strategies for the prevention of medication-induced nephrotoxicity
Explain the role of fluid and hemodynamic management in AKI recovery
Evaluate healthcare team member contributions to AKI management
Course Syllabus
I. Introduction
II. AKI Overview
III. KDIGO Diagnostic Criteria
IV. RIFLE Staging Criteria
A. AKIN Staging Criteria
B. Comparing Criteria
V. Epidemiology
VI. Etiology and Risk Factors
A. Prerenal AKI
B. Intrarenal AKI
C. Postrenal AKI
VII. Nephrotoxic Medications
VIII. Clinical Presentation and Diagnosis
A. History and Exam
B. Labs and Tests
C. New Biomarkers
IX. Preventing AKI
X. Managing AKI
A. Goals
B. Medication Management
C. Diuretics
XI. Interdisciplinary Collaboration
XII. Patient Education
XIII. Key Takeaways
XIV. Summary
How to Earn Live CE Webinar Credit
Participants are required to:
Read the learning objectives and faculty disclosures
Attend and participate in the live webinar
Complete an evaluation
RxCe.com uses gotowebinar to present live webinars. You must attend the full presentation in order to get credit for the activity. You are not able to listen to the webinar via telephone. RxCe.com will not grant credit to individuals who have not attended and participated in the full webinar. RxCe.com audits attendance and participation in order to be in compliance with ACPE standards.
- Read the course objectives and faculty planner disclosure
- Read the course material
- Complete the post-test with a minimum score of 70% and complete the course evaluation form.
- Results are automatically submitted to CPE Monitor
Faculty Planner Disclosure
The following individuals were involved in the development of this activity: Austin Fredrickson, MD, FACP, Liz Fredrickson, PharmD, BCPS, Kristina (Tia) Neu, RN, and Pamela M. Sardo, PharmD, BS. None of the individuals involved in developing this activity has a conflict of interest or financial relationships regarding the subject matter. There are no financial relationships or commercial or financial support relevant to this activity to report or disclose by RxCe.com or any of the individuals involved in the development of this activity.
Unlabeled Use Disclosures
The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.
Computer Hardware/Software Requirements
Please ensure the device you plan to use meets these requirements and specifications:
- Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
- Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
- A connection to the internet
- For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.
Rating: 4.76/5
Based on the ratings of 275 customers
- Target Audience: Pharmacist, Pharmacy Tech
- Secondary Audiences: This educational activity is also for other healthcare professionals, such as nurses, physicians, or others who may be part of a healthcare team and may be interested in this educational topic. A healthcare team approach to patient care may be discussed in this activity, as applicable. No state board or professional organization has evaluated this activity to determine whether it meets the continuing education requirements of nurses, physicians, or other professions not listed under the “Target Audience” described above. Always verify with individual employers or supervisors whether they will accept this educational activity upon completion.
- Contact Hours: 1.0 (0.1 CEUs)
- Post-test must be completed by: 1/27/2026}
- Activity Type: Knowledge
- UAN: 0669-0000-25-156-L01-P
- Topic: Disease State Management/Drug Therapy
- UAN Number: (Techs): 0669-0000-25-156-L01-T
- CeBroker Number: 20-1348172
Faculty:
RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
RxCe.com, LLC, offers pharmacy technician continuing education courses for PTCB recertification. Pharmacy technician courses are indicated both in the Target Audience description and the ACPE UAN which will end with a "T".